Literature DB >> 14622121

Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord.

F Labombarda1, S L Gonzalez, M C Gonzalez Deniselle, G P Vinson, M Schumacher, A F De Nicola, R Guennoun.   

Abstract

Progesterone provides neuroprotection after spinal cord injury, but the molecular mechanisms involved in this effect are not completely understood. In this work, expression of two binding proteins for progesterone was studied in intact and injured rat spinal cord: the classical intracellular progesterone receptor (PR) and 25-Dx, a recently discovered progesterone membrane binding site. RT-PCR was employed to determine their relative mRNA levels, whereas cellular localization and relative protein levels were investigated by immunocytochemistry. We observed that spinal cord PR mRNA was not up-regulated by estrogen in contrast to what is observed in many brain areas and in the uterus, but was abundant as it amounted to a third of that measured in the estradiol-stimulated uterus. In male rats with complete spinal cord transection, levels of PR mRNA were significantly decreased, while those of 25-Dx mRNA remained unchanged with respect to control animals. When spinal cord-injured animals received progesterone treatment during 72 h, PR mRNA levels were not affected and remained low, whereas 25-Dx mRNA levels were significantly increased. Immunostaining of PR showed its intracellular localization in both neurons and glial cells, whereas 25-Dx immunoreactivity was localized to cell membranes of dorsal horn and central canal neurons. As the two binding proteins for progesterone differ with respect to their response to lesion, their regulation by progesterone, their cellular and subcellular localizations, their functions may differ under normal and pathological conditions. These observations point to a novel and potentially important role of the progesterone binding protein 25-Dx after injury of the nervous system and suggest that the neuroprotective effects of progesterone may not necessarily be mediated by the classical progesterone receptor but may involve distinct membrane binding sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622121     DOI: 10.1046/j.1471-4159.2003.02055.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

Review 1.  Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination.

Authors:  Alejandro F De Nicola; Susana L Gonzalez; Florencia Labombarda; Maria Claudia González Deniselle; Laura Garay; Rachida Guennoun; Michael Schumacher
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.

Authors:  Chang Su; Rebecca L Cunningham; Nataliya Rybalchenko; Meharvan Singh
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 3.  Progesterone exerts neuroprotective effects after brain injury.

Authors:  Donald G Stein
Journal:  Brain Res Rev       Date:  2007-07-27

4.  Impact of continuous versus discontinuous progesterone on estradiol regulation of neuron viability and sprouting after entorhinal cortex lesion in female rats.

Authors:  Anna M Barron; Meghan A Brown; Todd E Morgan; Christian J Pike
Journal:  Endocrinology       Date:  2014-12-16       Impact factor: 4.736

Review 5.  New aspects of progesterone interactions with the actin cytoskeleton and neurosteroidogenesis in the cerebellum and the neuronal growth cone.

Authors:  Lisa Wessel; Laura Olbrich; Beate Brand-Saberi; Carsten Theiss
Journal:  J Histochem Cytochem       Date:  2014-08-20       Impact factor: 2.479

Review 6.  A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.

Authors:  Brian K Kwon; Elena Okon; Jessica Hillyer; Cody Mann; Darryl Baptiste; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-04-14       Impact factor: 5.269

Review 7.  PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.

Authors:  Hannah J Rohe; Ikhlas S Ahmed; Katherine E Twist; Rolf J Craven
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

8.  Progesterone effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (MAP2) in rats with acute spinal cord injury.

Authors:  Susana L González; Juan José López-Costa; Florencia Labombarda; Maria Claudia González Deniselle; Rachida Guennoun; Michael Schumacher; Alejandro F De Nicola
Journal:  Cell Mol Neurobiol       Date:  2008-06-27       Impact factor: 5.046

9.  Stage dependent effects of progesterone on motoneurons and glial cells of wobbler mouse spinal cord degeneration.

Authors:  Maria Meyer; Maria Claudia Gonzalez Deniselle; Laura I Garay; Gisella Gargiulo Monachelli; Analia Lima; Paulina Roig; Rachida Guennoun; Michael Schumacher; Alejandro F De Nicola
Journal:  Cell Mol Neurobiol       Date:  2009-08-20       Impact factor: 5.046

10.  Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.